77
Spot Diagnosis Rheumatology Weekend 20-21 Nov. 2010

Spot Diagnosis

Embed Size (px)

Citation preview

Page 1: Spot Diagnosis

Spot Diagnosis Rheumatology Weekend

20-21 Nov. 2010

Page 2: Spot Diagnosis

Describe, Dx, Ab asso

Page 3: Spot Diagnosis

Mechanic Hand

•  Hyperkeratosis and fissure of radial side of 2nd to 4th fingers and ulnar side of thumb

•  Associate with antisynthetase syndrome •  Antibody associated: Anti aminoacyl tRNA

synthetase •  Anti histidyl tRNA synthetase or anti Jo-1

Page 4: Spot Diagnosis

Diagnosis

Page 5: Spot Diagnosis

Dermatomyositis

•  Pathogenesis: Immune complex to vessel •  Ischemia due to vasculitis •  Pathology: perivascular and perifascicular

infiltration (CD4); perifascicular fiber atrophy; degeneration and regeneration of muscle

Page 6: Spot Diagnosis

Diagnosis, DDx

Page 7: Spot Diagnosis

Calcinosis Cutis

•  Abnormal calcification of subcutaneous tissue

•  DDx: tophi, xanthoma, Heberden and Bouchard’s node

Page 8: Spot Diagnosis

Diagnosis

Page 9: Spot Diagnosis

Lupus Panniculitis

•  Panniculitis in LE •  Mostly found at face and limb girdles •  Post inflammation cause atrophy •  Lupus profundus

Page 10: Spot Diagnosis

What test

Page 11: Spot Diagnosis

Anti dsDNA

•  Crithidia leuciliae •  Crithidia test is gold standard of anti

dsDNA test •  ELISA test: titer relate to disease activity in

LN

Page 12: Spot Diagnosis

Diagnosis

Page 13: Spot Diagnosis

Morphea

•  Localized scleroderma •  Morphea type: patchy and ivory-colored •  Linear type: band-liked

Page 14: Spot Diagnosis

What

Page 15: Spot Diagnosis

Secondary RP

•  Clue of secondary RP Age of onset older than 30 Asymmetrical Abnormal nailfold capillary Abnormal serology Abnormal CBC or ESR/CRP Severe pain and/or develop digital ulcer, digital pitting, gangrene

Page 16: Spot Diagnosis

What

Page 17: Spot Diagnosis

Periungual Infarction

•  Small to medium vasculopathy or vasculitis

•  Seen in SLE, DM, SS, MCTD

Page 18: Spot Diagnosis

Diagnosis

Page 19: Spot Diagnosis

SSc-Pattern Nailfold Cap.

•  Early: dilatation of capillary turn to giant capillary, well-preserved distribution

•  Active: more dilatation and microhemorrhage, mild disorganization

•  Late: almost absence dilatation and hemorrhage, ramified neovascularization and intense disorganization

Page 20: Spot Diagnosis

VEDOSS

•  Very Early Diagnosis of SSc •  Major criteria: SSc pattern nailfold cap.;

Serology; RP •  Minor criteria: calcinosis cutis; esophageal

sphincter dysfunction; puffy fingers; digital ulcers; telangiectasia; ground-glass at chest HRCT

•  Diagnosis: 3 majors or 2 majors and 1 minor

Page 21: Spot Diagnosis

Diagnosis

Page 22: Spot Diagnosis

Discoid LE

•  Chronic cutaneous LE •  Involve skin appendage cause atrophic

scar •  Typical: erythema or hypertrophic patch,

papule, plaque with follicular plugging and some atrophic center and telangiectasia

Page 23: Spot Diagnosis

What

Page 24: Spot Diagnosis

Cytoid Bodies

•  Retinal vasculitis •  Cause exudate and hemorrhage of fundus •  Relate to active vasculitis

Page 25: Spot Diagnosis

How does it relate to SLE

Page 26: Spot Diagnosis

Sapporo

•  Sapporo Snow Festival •  APS meeting Sapporo criteria 1999 •  Nowadays: Sydney 2006

Page 27: Spot Diagnosis

What

Page 28: Spot Diagnosis

GAVE

•  Gastric Antral Vascular Ectasia •  Vasculopathy manifestation •  Anemia in SSC

Page 29: Spot Diagnosis

What and asso. Ab

Page 30: Spot Diagnosis

Rheumatoid Nodule

•  Granuloma like: central necrosis and palisading histiocytes

•  Associate with RF and ACPA •  Increase prevalence in A2756G

polymorphism of methionine synthase reductase gene

•  MTX induced nodularis

Page 31: Spot Diagnosis

What

Page 32: Spot Diagnosis

Tophi

•  Granuloma like: central micro-crystal and surrounding macrophage

•  Alcohol fixation

Page 33: Spot Diagnosis

Diagnosis

Page 34: Spot Diagnosis

Eosinophilic Fasciitis

•  Groove sign: furrows along fascia and blood vessels

•  DDx in scleroderma-liked: EF; scleredema; nephrogenic systemic fibrosis; post CMT, bleomycin; GVHD

Page 35: Spot Diagnosis

Antibody associated

Page 36: Spot Diagnosis

Anti-Ro and Anti-La

•  Neonatal lupus •  Associate antibodies: anti Ro/SSA and

anti La/SSB •  Manifestation: skin, hemato, liver, cardio •  Fluorinated steroid: dexamethasone and

betamethasone for cardiac involvement

Page 37: Spot Diagnosis

Antibody related

Page 38: Spot Diagnosis

Antiphospholipid

•  Anticardiolipin: 40 units or 99th percentile of IgG or IgM

•  Anti β 2 glycoprotein I: 99th percentile of IgG or IgM

•  Anti phosphatidylserine •  Anti phosphatidylethanolamine

Page 39: Spot Diagnosis

What

Page 40: Spot Diagnosis

Erythema Ab Igne

•  Differential diagnosis of livedo reticularis •  Long term exposure to heat •  Reticulated hyperpigmentation

Page 41: Spot Diagnosis

Diagnosis

Page 42: Spot Diagnosis

Scleroderma

•  Vasculopathy: intema media thickening •  Fibrosis: loss of normal architecture of

dermal ridge, abnormal collagen bundle, loss of skin appendages

Page 43: Spot Diagnosis

Diagnosis

Page 44: Spot Diagnosis

Sjogren Syndrome

•  Inflammation of exocrine gland •  Autoimmune process: alpha frodin •  Anti Ro, anti La, RF •  Sicca symptom of eyes and mouth •  Mikculicz disease •  CD4 infiltration

Page 45: Spot Diagnosis

How does she relate to SLE

Page 46: Spot Diagnosis

Ultraviolet

•  Trigger of SLE flare: UVB 290-310 nm •  Exposure of anti Ro and apoptosis of

keratinocyte

Page 47: Spot Diagnosis

What test

Page 48: Spot Diagnosis

Tinel Sign

•  Carpal tunnel syndrome •  Associate: diabetes, hypothyroid, RA, SSc

crystal induced arthropathy, pregnancy, amyloidosis, mechanic use

Page 49: Spot Diagnosis

Diagnosis

Page 50: Spot Diagnosis

Sjogren Syndrome

•  Sialogram: cherry-blossom appearance (budding) of salivary duct

Page 51: Spot Diagnosis
Page 52: Spot Diagnosis

How dose it relate to SS

Page 53: Spot Diagnosis

Rose Bengal

•  Rose Bengal dye •  Keratoconjunctivitis sicca •  Schirmer’ test: less than 5 mm. within 5

min. •  Saxon test: weighing of chewed-gauze

Page 54: Spot Diagnosis

Diagnosis

Page 55: Spot Diagnosis

Parry-Romberg Syndrome

•  Progressive hemifacial atrophy •  Skin and bone atrophy •  Seizure

Page 56: Spot Diagnosis

En Coup de Sabre

•  Long streak resembling sabre wound

Page 57: Spot Diagnosis

Diagnosis

Page 58: Spot Diagnosis

Pannus

•  Lymphoid follicle-like in synovial tissue •  Cytokine-driven: TNF alpha, IL-1, IL-2,

IL-6, IL-17, IL-23

Page 59: Spot Diagnosis

Granuloma

Page 60: Spot Diagnosis

How relate to rheu. disease

Page 61: Spot Diagnosis

Saturnine Gout

•  Lead poisoning and gout •  Roman God Saturn festival: heavy wine

drinking from lead-lined goblet

Page 62: Spot Diagnosis

Diagnosis

Page 63: Spot Diagnosis

Polyarteritis Nodosa

•  PAN: medium-vessel vasculitis •  HBV-related and non HBV-related •  HBV-related treatment: antivirals, plasma

exchange and high-dose steroid •  Non HBV-related treatment: high-dose

steroid and cyclophosphamide

Page 64: Spot Diagnosis

DDx

Page 65: Spot Diagnosis

Saddle Nose

•  Rheum.: WG, relapsing polychondritis •  Hem.: NK/T cell lymphoma •  ID.: leprosy

Page 66: Spot Diagnosis

Diagnosis

Page 67: Spot Diagnosis

Scleromalacia

•  Episcleritis and scleritis are most common •  Thinning of sclera: scleromalacia •  Protrusion of vitreous body: scleromalacia

perforans

Page 68: Spot Diagnosis

Diagnosis

Page 69: Spot Diagnosis

Anterior Uveitis

•  Ciliary injection and hypopyon •  Extra-articular symptom of SpA •  AS: more unilateral •  ReA: more bilateral

Page 70: Spot Diagnosis

How dose picture relate to rheu.

Page 71: Spot Diagnosis

Poliosis

•  Poliosis: absence or decrease melanin of hair

•  VKH: Vogt-Konayagi-Harada syndrome •  Autoimmune against melanin-containing

organ •  Neuro: meningitis, stroke-liked, CN palsy •  Eye: uveitis •  Skin: poliosis, vitiligo

Page 72: Spot Diagnosis

Name of mab(s) against this

Page 73: Spot Diagnosis

Rituximab/Ocrelizumab

Page 74: Spot Diagnosis

Mab against this

Page 75: Spot Diagnosis

Tocilizumab

Page 76: Spot Diagnosis

Biological agents against this

Page 77: Spot Diagnosis

Anti-TNF alpha

•  Etanercept: fusion protein against soluble TNF receptor

•  Infliximab: chimerical mouse-human mab •  Adalimumab: fully-humanized mab •  Golimumab: fully-humanized mab •  Certolizumab : pegylated-humanized mab